AbbVie Small Cell Lung Cancer Treatment (An Antibody Drug Conjugate Comprising Monoclonal Antibody Anti-SEZ6 IgG1 Antibody Conjugated To A Top1 Inhibitor) Granted FDA Orphan Designation
AbbVie Small Cell Lung Cancer Treatment (An Antibody Drug Conjugate Comprising Monoclonal Antibody Anti-SEZ6 IgG1 Antibody Conjugated To A Top1 Inhibitor) Granted FDA Orphan Designation
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.